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We thank Osnabrugge and col-
leagues for their interest in our article
and appreciate their comments on the
statistical methodology that we adop-
ted for the comparison between the
survival of elderly patients undergo-
ing aortic valve replacement (AVR)
and the expected survival of the age-
and sex-matched general population.
We acknowledge that the method
suggested by Osnabrugge and col-
leagues should be applied in studies
with extended long-term follow-up, be-
cause of a strong correlation between
age and length of follow-up, to avoid
underestimation of the general popula-
tion survival. This statistical method is
validated for long-term follow-up, but
it is needed less1 for studies with short
follow-up, such as our own, in which it
is possible to assume thatwithdrawal at
different times does not affect the esti-
mates of survival. As a matter of fact, it
is not surprising that, among many,1290 The Journal of Thoracic andsuch authoritative Institutions as The
Cleveland Clinic,2 the New York State
Department of Health’s Cardiac Sur-
gery Reporting System,3 and others4
have recently used the same methodol-
ogy as we to compare the dynamic sur-
vival of a surgical population with the
static expected survival of a corre-
sponding age- and sex-matched gen-
eral population.
Moreover, we do not find it intui-
tively apparent that survival after
AVR is unlikely to be comparable to
that of the general population unless
there is a strict selection of patients,
as speculated by Osnabrugge and col-
leagues when referring to our study
cohort. We note that (1) a surgical
population is selected by definition
(see the limitations of our study listed
in the article), (2) progressive accu-
mulation of interstitial myocardial fi-
brosis may be present in elderly
subjects with or without aortic valve
stenosis, and (3) we reported the pre-
operative characteristics of our pa-
tients, and our findings are consistent
with much growing and converging
evidence indicating that long-term
survival of octogenarian patients can
be equal to the expected survival of
an age- and gender-matched popula-
tion, which should not be neglected
by Osnabrugge and colleagues.2,4,5
Any attempt to explain such a favor-
able outcome after AVR in the elderly
population can only be speculative
and thus will not be the subject of dis-
cussion here. It may, however, have
something to do with a lower cumula-
tive incidence of tissue valve–related
complications in elderly patients
with limited life spans, with a higher
incidence of cardiac events among
people with severe aortic valve steno-Cardiovascular Surgery c November 20sis who do not undergo AVR, and with
the exclusion—as in our series—of
patients undergoing associated myo-
cardial revascularization and/or redo
operations.
We apologize for the mentioned
errors of transcription from figures to
text. A significant (P<.001) survival
difference was observed between pa-
tients operated on in New York Heart
Association functional class III or IV
and those operated on in functional
class I or II. In addition, the 2-year
survival for the group undergoing
AVR after the age of 80 years group
was in fact 87.4%.
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